TickerFacts.

Mimedx Group, Inc. (MDXG): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$166.12M
As of 2025-12-31
$135.84M
As of 2026-06-30
+36.1%
3-year compound annual growth
+11.6%
5-year compound annual growth
2010-12-31: $1.34M2011-12-31: $4.11M2012-12-31: $6.75M2013-12-31: $44.08M2014-12-31: $46.58M2015-12-31: $28.49M2016-12-31: $30.32M2017-12-31: $27.48M2018-12-31: $45.12M2019-12-31: $69.07M2020-12-31: $95.81M2021-12-31: $87.08M2022-12-31: $65.95M2023-12-31: $82.00M2024-12-31: $104.42M2025-12-31: $166.12M$166.12M
2010-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$166.12M+59.1%2026-02-25, Balance as of period end
2024-12-31$104.42M+27.3%2026-02-25, Balance as of period end
2023-12-31$82.00M+24.3%2025-02-26, Balance as of period end
2022-12-31$65.95M-24.3%2024-02-28, Balance as of period end
2021-12-31$87.08M-9.1%2023-02-28, Balance as of period end
2020-12-31$95.81M+38.7%2022-02-28, Balance as of period end
2019-12-31$69.07M+53.1%2021-03-08, Balance as of period end
2018-12-31$45.12M+64.2%2020-07-06, Balance as of period end
2017-12-31$27.48M-9.4%2020-03-17, Balance as of period end
2016-12-31$30.32Mn/c2020-03-17, Balance as of period end
2015-12-31$28.49M-38.8%2017-03-01, Balance as of period end
2014-12-31$46.58M+5.7%2017-03-01, Balance as of period end
2013-12-31$44.08M+552.6%2017-02-22, Balance as of period end
2012-12-31$6.75M+64.2%2015-03-13, Balance as of period end
2011-12-31$4.11M+206.7%2014-03-04, Balance as of period end
2010-12-31$1.34Mn/a2012-03-29, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Mimedx Group, Inc. (MDXG)2025-12-31$166.12M+59.1%
Accuray Inc (ARAY)2026-06-30$40.62M-29.2%
Artivion, Inc. (AORT)2025-12-31$64.91M+21.4%
Glaukos Corp (GKOS)2025-12-31$90.81M-46.5%
Tactile Systems Technology Inc (TCMD)2025-12-31$83.45M-11.6%
AtriCure, Inc. (ATRC)2025-12-31$167.43M+36.4%
Angiodynamics Inc (ANGO)2026-05-31$53.86M-3.6%
Bioventus Inc. (BVS)2025-12-31$51.24M+23.2%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$286.50M-14.1%

Compare MDXG, ARAY, AORT, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗